Ubs Group Ag Simulations Plus, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 14,710 shares of SLP stock, worth $417,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,710
Previous 10,175
44.57%
Holding current value
$417,028
Previous $494,000
4.86%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding SLP
# of Institutions
175Shares Held
15.1MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$69.9 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$54.9 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$32.6 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$25.6 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$18.2 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $575M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...